Profitelligence Profitelligence · Filing Ledger Open MCK research →

Form 8-K · Current Report · Filed 2026-07-01

McKesson Appoints New Chief Strategy Officer

On June 29, 2026, McKesson Corporation announced the retirement of Thomas L.

Filer
McKesson Corporation MCK · NYSE
Filed
Accession
0000927653-26-000185
CIK
0000927653
Signal
High impactHealthcare

Details

Rodgers, Executive Vice President and Chief Strategy and Business Development Officer, effective August 1, 2026. To ensure a smooth transition, Ramesh Srinivasan has been appointed as the new Executive Vice President and Chief Strategy Officer, also effective August 1, 2026. This transition is part of a planned succession strategy to maintain continuity in the company's strategic direction.

Items reported

Item events

Reported Item

Key Executive Departure Key Executive Appointment

Market reaction

Close before filing

$755.60

Next session

+4.1%

Since filing

+13.3%

Latest close

$856.19

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from MCK reporting the same item, with the next session's move:

Insider tape

Within 45 days of this filing, MCK insiders reported 103 Form 4 transactions — net selling of $44.4M.

Full MCK insider history →

About McKesson Corporation

McKesson Corporation is a leading healthcare services and information technology company. It plays a crucial role in the distribution of pharmaceuticals and medical products. The primary function of McKesson is to ensure the efficient delivery of healthcare products to pharmacies, hospitals, and other medical facilities, ensuring that millions of patients have access to the medications they need. It also provides specialized software and automated solutions that enhance operational efficiency in healthcare sectors. McKesson significantly impacts the pharmaceutical and healthcare industries by offering solutions that streamline supply chains and improve patient care. Its services encompass wholesale drug distribution, healthcare IT systems, and pharmacy management. With operations that extend globally, McKesson is integral to maintaining the integrity and reliability of healthcare supply networks. By handling a substantial portion of the pharmaceutical distribution in North America, McKesson Corporation has a vital market presence, emphasizing its importance in shaping healthcare logistics and innovation. Its efforts contribute to advancing healthcare delivery and responding to the evolving demands of the medical industry.

Exchange NYSE Industry Medical Distribution Company website ↗

Never miss another MCK filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts